These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9091474)

  • 1. Cyclosporine as maintenance therapy in patients with severe psoriasis.
    Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
    Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
    Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis relapse evaluation with week-end cyclosporine A treatment: results of a randomized, double-blind, multicenter study.
    Colombo D; Cassano N; Altomare G; Giannetti A; Vena GA
    Int J Immunopathol Pharmacol; 2010; 23(4):1143-52. PubMed ID: 21244763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
    Yoon HS; Youn JI
    J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.
    Micali G; Wilsmann-Theis D; Mallbris L; Gallo G; Marino V; Brault Y; Germain JM
    Acta Derm Venereol; 2015 Jan; 95(1):57-61. PubMed ID: 24682319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
    Ellis CN; Fradin MS; Messana JM; Brown MD; Siegel MT; Hartley AH; Rocher LL; Wheeler S; Hamilton TA; Parish TG
    N Engl J Med; 1991 Jan; 324(5):277-84. PubMed ID: 1986287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study.
    Grossman RM; Thivolet J; Claudy A; Souteyrand P; Guilhou JJ; Thomas P; Amblard P; Belaich S; de Belilovsky C; de la Brassinne M
    J Am Acad Dermatol; 1994 Jul; 31(1):68-74. PubMed ID: 8021375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
    Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
    J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
    Dermatology; 1993; 187 Suppl 1():19-29. PubMed ID: 8369576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
    Thaçi D; Bräutigam M; Kaufmann R; Weidinger G; Paul C; Christophers E
    Dermatology; 2002; 205(4):383-8. PubMed ID: 12444336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.
    Rich P; Sigurgeirsson B; Thaci D; Ortonne JP; Paul C; Schopf RE; Morita A; Roseau K; Harfst E; Guettner A; Machacek M; Papavassilis C
    Br J Dermatol; 2013 Feb; 168(2):402-11. PubMed ID: 23362969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent vs. continuous 1-year cyclosporin use in chronic plaque psoriasis.
    Chaidemenos GC; Mourellou O; Avgoustinaki N; Papakonstantinou M; Karakatsanis G; Katsambas A
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1203-8. PubMed ID: 17894706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.
    Papp K; Cather JC; Rosoph L; Sofen H; Langley RG; Matheson RT; Hu C; Day RM
    Lancet; 2012 Aug; 380(9843):738-46. PubMed ID: 22748702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis.
    Mohanan S; Ramassamy S; Chandrashekar L; Thappa DM
    J Dermatolog Treat; 2014 Feb; 25(1):50-3. PubMed ID: 23469768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.